000			02188nam a2200241Ia 4500
003			ASM
005			20241206092904.0
008			241203s9999 xx 000 0 und d
010			_aHD9999.B442
020			_a97815913984
020			_a9781591398400
020			_qHardback
040			_cASM
050			_a
100			_aGary P. Pisano _eAuthor
245		0	_aScience Business : _b"The Promise, The Reality and the Future of Biotech" _cGary P. Pisano.
260			_a"Boston, Massachusetts" _bHarvard Business School Press _c2006
300			_a237 Pages _b"Graphs, Flow charts, Bars" _c24 cm
520			_a"Why has the biotechnology industry failed to perform up to expectations—despite all its promise? In Science Business, Gary P. Pisano answers this question by providing an incisive critique of the industry. Pisano not only reveals the underlying causes of biotech's problems; he offers the most sophisticated analysis yet on how the industry works. And he provides clear prescriptions for companies, investors, and policy makers seeking ways to improve the industry's performance. According to Pisano, the biotech industry's problems stem from its special character as a science-based business. This character poses three unique business challenges: how to finance highly risky investments under profound uncertainty and long time horizons for R&D, how to learn rapidly enough to keep pace with advances in drug science knowledge, and how to integrate capabilities across a broad spectrum of scientific and technological knowledge bases.The key to fixing the industry? Business models, organisational structures, and financing arrangements that place greater emphasis on integration and long-term learning over shorter—term 'monetisation' of intellectual property. Pisano maintains that all industry players—biotech firms, investors, universities, pharmaceutical companies, government regulators—can play a role in righting the industry. The payoff? Valuable improvements in health care, and a shinier future for human well-being."
546			_aEnglish
650			_a"Social Sciences-Miscellaneous industries and trades, Biotechnology industries--History."
942			_cBooks
999			_c4356 _d4356